Core B - Mutant Mouse
Core B - Mutant Mouse
批准号:
10239107
负责人:
Dario AA Vignali
金额:
$45.61万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-05-15 至 2025-07-31
关键词:
Adoptive TransferAgeAutoimmune DiseasesAutoimmunityBiologicalBreedingBudgetsCD8-Positive T-LymphocytesCD8B1 geneChronicCollectionCommunitiesComplexDataDiseaseDissectionEmbryoEnsureEnterobacteria phage P1 Cre recombinaseFOXP3 geneFemaleGenesGeneticGenotypeHealth StatusImmunityImmunologicsInbred Strains MiceIndividualLeadLoxP-flanked alleleMalignant NeoplasmsMediatingMonitorMusMutant Strains MiceProductionQuarantineRag1 MouseRegulationRegulatory T-LymphocyteResearchResearch PersonnelResourcesRoleSchemeShippingShipsSiteStainsSystemT cell therapyT-LymphocyteTimeTumor ImmunityUniversitiesVariantVirus DiseasesWorkantiviral immunitycell typechronic infectioncostcost effectivedesignexhaustexperimental studyflexibilitygenetic elementimmunoregulationin vivoinsightmalemicrobiotamouse developmentmouse modelpathogenperformance sitepreventprogrammed cell death protein 1programsreceptorrepositorysperm cellsynergismtherapeutic targettherapeutically effectivetooltumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CORE SUMMARY
The Mutant Mouse Core (Core B) is an essential core that will be used extensively by all three projects. Given
the complex interplay between different inhibitory receptors on multiple cell types, the only way one can dissect
these critical disease-related biological questions in vivo is with sophisticated mouse models. A significant
strength of this PPG application is the unique `immunological toolbox' that it will utilize, specifically PD1/LAG3
floxed mice combined with a unique collection of lineage-specific, and in most instances temporally controlled,
Cre recombinase-expressing mice. These tools will give us unprecedented control and thus insight into
PD1/LAG3 synergy and function in multiple cell types.
AIM 1: To provide required PD1/LAG3 mutant mice. The Core will be administered from the University of
Pittsburgh (Pitt), with the majority of the mutant mouse breeding and procurement outsourced to Taconic under
Murine Pathogen Free barrier conditions identical to the majority of their commercial breeding practices. Taconic
will deliver mice to all research sites on a rotating bi-weekly basis using their conventional delivery mechanism,
thereby avoiding lengthy quarantine.
AIM 2: To generate new mutant mouse combinations. The Core will generate new mutant mouse
combinations that introduce different genetic elements such as new Cre stains.
PPG Interactions: Core B will support Project 1, Project 2 and Project 3 extensively, and interact with Core
A to provide easy access to breeding, shipping and genotyping data. Core B will also perform additional crosses
to generate any strain combinations required by the projects. Core B will interact with Core A to provide easy
access to breeding, shipping and genotyping data and ongoing monitoring.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory T cells and the tumor microenvironment
-
批准号:10454307
-
项目类别:
-
资助金额:$90.64万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
-
批准号:10683756
-
项目类别:
-
资助金额:$36.97万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
-
批准号:10469635
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Regulatory T cells and the tumor microenvironment
-
批准号:10298246
-
项目类别:
-
资助金额:$92.79万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Regulatory T cells and the tumor microenvironment
-
批准号:10670939
-
项目类别:
-
资助金额:$90.64万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
-
批准号:10270231
-
项目类别:
-
资助金额:$36.39万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Interleukin-35 and the tumor microenvironment
-
批准号:9306799
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2016
-
负责人:Dario AA Vignali
-
依托单位:
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
-
批准号:10670296
-
项目类别:
-
资助金额:$44.51万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core A - Administrative Core
-
批准号:10239106
-
项目类别:
-
资助金额:$17.39万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core A - Administrative Core
-
批准号:10023664
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity
-
批准号:10470821
-
项目类别:
-
资助金额:$231.17万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core A - Administrative Core
-
批准号:10663572
-
项目类别:
-
资助金额:$15.35万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Modulation of Anti-Tumor Immunity by Inhibitory Receptors
-
批准号:8854453
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core B - Mutant Mouse
-
批准号:10023665
-
项目类别:
-
资助金额:$45.85万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
-
批准号:10239112
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Synergies among inhibitory receptors in tolerance, cancer and antiviral immunity
-
批准号:8854446
-
项目类别:
-
资助金额:$222.34万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity
-
批准号:10670290
-
项目类别:
-
资助金额:$231.17万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core B - Mutant Mouse
-
批准号:10670292
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
-
批准号:10663577
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core B - Mutant Mouse
-
批准号:10663573
-
项目类别:
-
资助金额:$47.59万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: